Perioperative esmolol infusion for haemodynamic stability during major vascular surgery. - Perioperative esmolol infusion

Erasmus Medical Centre0 个研究点开始时间: 2010年7月27日最近更新: 2012年3月19日

试验速览

暂无简介。

•Patients are eligible for inclusion for the study at the Erasmus Medical Centre if they are:
•1. Scheduled for arterial vascular surgery, including abdominal aortic aneurysm repair, abdominal aortic stenosis surgery, lower limb arterial reconstruction or carotid artery stenosis repair
•2. Provide informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Potential subjects will be excluded with any of the following:
•1. Active bleeding
•2. Untreated left main disease
•3. Active cardiac condition such as unstable angina pectoris, active congestive heart failure, serious cardiac arrhythmias, symptomatic valvular disease, recent MI< 6 months.
•4. Preoperative positive troponin T
•5. Contraindication for esmolol use
•6. Previous allergy or intolerance to esmolol
•7. Cancer with an expected life expectancy < 6 months
•8. Excessive alcohol use
•9. Pregnancy or planning to become pregnant
•10. Failure to provide informed consent
•11.Failure to monitor heart rate with the continuous 12-lead electrocardiography because of surgery or baseline electrocardiographic abnormalities.

发起方

Erasmus Medical Centre